Biomarkers to Establish Low ASCVD Risk: It Takes Two

John W McEvoy; Chee H Liew; Niall P Connolly

doi:10.1016/j.jacc.2020.06.002

Biomarkers to Establish Low ASCVD Risk: It Takes Two

J Am Coll Cardiol. 2020 Jul 28;76(4):371-373. doi: 10.1016/j.jacc.2020.06.002.

Authors

John W McEvoy¹, Chee H Liew², Niall P Connolly²

Affiliations

¹ Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland; School of Medicine, National University of Ireland Galway, Galway, Ireland. Electronic address: johnwilliam.mcevoy@nuigalway.ie.
² School of Medicine, National University of Ireland Galway, Galway, Ireland.

PMID: 32703506
DOI: 10.1016/j.jacc.2020.06.002

No abstract available

Keywords: atherosclerotic cardiovascular disease; coronary artery calcium; high-sensitivity cardiac troponin; primary prevention; risk stratification.

Publication types

Editorial
Comment

MeSH terms

Biomarkers
Calcium
Cardiovascular Diseases* / diagnosis
Cardiovascular Diseases* / epidemiology
Coronary Artery Disease*
Humans
Risk Assessment
Troponin

Substances

Biomarkers
Troponin
Calcium